Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Supportive Care

21 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Diagnostic

    Miscellaneous

    VICCSAR1458

    04/22/2015

    F18-FES PET/CT Imaging of Desmoid Tumors

    Health Services Research

    Retinoblastoma (Pediatrics)

    VICCREACH1447

    04/16/2014

    Retinoblastoma Survivor Study (RBSS)

    Other

    Breast - Female

    VICC090513-M

    01/25/2012

    Arthralgia in women with early stage breast cancer taking aromatase inhibitors: the Breast Cancer Adjuvant Therapy (BCAT) longitudinal cohort/registry study

    Other

    Breast

    ECOGBREE2Z04-M

    06/11/2008

    Quality of LIfe in Younger Breast Cancer Survivors

    Prevention

    Liver

    VICCPED1698

    06/23/2017

    A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant

    Prevention

    Breast

    VICCBRE1438

    06/19/2014

    A Randomized Trial Evaluating Bioimpedance Spectroscopy versus Tape Measurement in the Prevention of Lymphedema following Locoregional Treatment for Breast Cancer

    Supportive Care

    Lung

    VICCTHO1657

    10/14/2016

    A Pivotal Multi-Center, Randomized, Controlled, Single-Blinded Study Comparing the Silver Nitrate-Coated Indwelling Pleural Catheter (SNCIPC) to the Uncoated PleurX? Pleural Catheter for the Management of Symptomatic, Recurrent, Malignant Pleural Effusions

    Supportive Care

    Neuro-Oncology

    NRGNEUCC001

    07/14/2016

    A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastases

    Supportive Care

    Pediatric Leukemia
    Pediatric Lymphoma
    Pediatric Supportive Care

    COGACCL1333

    04/28/2016

    A Phase III Randomized, Open Label, Multi-center Study on the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated (PEG) L-Asparaginase

    Supportive Care

    Head/Neck

    VICCSUPP1529

    06/08/2015

    Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

    Supportive Care

    Pediatric Supportive Care

    VICCPED1389

    11/13/2013

    Canines and Childhood Cancer (CCC) Full Trial

    Supportive Care

    Breast - Female

    ALLIANCEA221102-M

    11/06/2012

    Randomized study of subQ testosterone in the adjuvant treatment of postmenopausal women with aromatase inhibitor induced arthralgias

    Treatment

    Cervical

    VICCGYN16105

    06/26/2017

    Phase III Study of ADXS11-001 Administered Following Chemoradiation As Adjuvant Treatment For High Risk Locally Advanced Cervical Cancer

    Treatment

    Hematologic

    VICCBMT16110

    03/10/2017

    A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

    Treatment

    Neuro-Oncology

    ECOGNEUA221208

    01/18/2017

    Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis after Radiosurgery for Brain Metastases

    Treatment

    Lung
    Neuroendocrine

    VICCTHO15115

    11/08/2016

    A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study Of The Efficacy And Safety Of Lanreotide Autogel/ Depot 120 Mg Plus Bsc Vs. Placebo Plus Bsc For Tumour Control In Subjects With Well Differentiated, Metastatic And/Or Unresectable Typical Or Atypical Lung Neuroendocrine Tumours

    Treatment

    Leukemia

    VICCHEM1597

    02/17/2016

    A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation

    Treatment

    Multiple Myeloma

    VICCHEM15112

    01/11/2016

    A Phase 1/2 Open-label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-8602 in Patients with Relapsed/Refractory Cancer Indications

    Treatment

    Bladder
    Urologic

    ECOGUROEA8141

    08/27/2015

    A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma

    Treatment

    Neuroblastoma (Pediatrics)

    COGANBL1232

    08/20/2014

    Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

    Treatment

    Hodgkin's Lymphoma
    Leukemia, other
    Lymphoid Leukemia
    Multiple Myeloma
    Myeloid and Monocytic Leukemia
    Non-Hodgkin's Lymphoma
    Other Hematopoietic

    VICCNCPED1414

    04/24/2014

    HLA-haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and other Nonmalignant Disorders Using Conditioning with Low-Dose Cyclophosphamide, TBI and Fludarabine; Postgrafting Immunosuppression will Consist of a Single Low Dose of Cyclophosphamide, MMF and Tacrolimus


    Print this page for your doctor